Gene therapy—is it really a sound investment prospect?
Article in TrialSite News
Daniel O’Connor, founder and CEO TrialSite News
I’ve been having some great conversations with Daniel O’Connor at TrialSite News.
Here are the publication’s Mission & Values:
TrialSite’s mission is to drive awareness, introduce transparency, and facilitate engagement among people all over the world, from pharmaceutical professionals and academic researche…